Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid Patients

IMPORTANCE: Cardiovascular death remains the leading cause of mortality in patients with type 2 diabetes (T2D). A better understanding of the current use and adoption of glucose-lowering drugs with cardiovascular benefit can inform state policies to ensure their appropriate use in patients with T2D....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Mike Z., Avorn, Jerry, Liu, Jun, Kesselheim, Aaron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644265/
https://www.ncbi.nlm.nih.gov/pubmed/36346634
http://dx.doi.org/10.1001/jamanetworkopen.2022.40117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644265/
https://www.ncbi.nlm.nih.gov/pubmed/36346634
http://dx.doi.org/10.1001/jamanetworkopen.2022.40117

Ejemplares similares